Alessandro Doria
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease (NCT06217302) | Alessandro Doria | 2024-10-31 |
| A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes (NCT04929379) | Alessandro Doria | 2022-01-04 |
Track Alessandro Doria automatically
Every clearance here is in the API, with alerts when new ones post.